Home
Journal Information
About
Aims and Scope
Contacts and Editorial Office
Editorial Board
Editor in Chief
Publisher
Conflicts of Interest
Editorial Policies
Publication Ethics
Nickan Research Institute policy
DISCLAIMER
Open Access
Journal Issues
Current Issue
In Press
Archive
Guidelines
For Authors
For Authors-New
For Reviewers
Peer Review Process in JRIP
Peer Review Process flowchart in JRIP
Authors agreement form
Checklist for review
Editorial Workflow
Publication Ethics and Malpractice Statement
Human and animal right
Informed Consent
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Aims and Scope
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
J Renal Inj Prev
. 2017;6(1): 65-69. doi:
10.15171/jrip.2017.12
PMID:
28487875
PMCID:
PMC5414522
Original Article
Impact of sertraline on serum concentration of CRP in hemodialysis patients with depression
Narges Sadat Zahed, Marjan Sharifi * , Mahdi Karimi, Hajar Nikbakht
Cited by CrossRef: 14
1- Fidan E, Gormus Z, Kilinc İ, İyisoy M, Gormus N. Effects of Combined Sertraline and Magnesium in Rat Atrium.
Biol Trace Elem Res
. 2022;200(2):652
[Crossref]
2- Molin C, Sakae T, Schuelter-Trevisol F, Trevisol D. Effects of sertraline in the prevention of low blood pressure in patients undergoing hemodialysis.
Braz J Nephrol
. 2019;41(4):492
[Crossref]
3- Khameslo M, Tofighi A, Azar J, Hosseini S, Mehdirji H, Khameslo M. The effects of aerobic exercise and sertraline on pro-inflammatory indices and amelioration of neurotrophic factors in patients who have undergone CABG.
Sport Sci Health
. 2023;19(3):969
[Crossref]
4- Assimon M, Brookhart M, Flythe J. Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
JASN
. 2019;30(4):611
[Crossref]
5- Zhang S, Xu Y, Xia Y. The efficacy and safety of sertraline in maintenance hemodialysis patients with depression: A randomized controlled study.
Journal of Affective Disorders
. 2024;352:60
[Crossref]
6- Song X, Zhang Z, Zhang R, Wang M, Lin D, Li T, Shao J, Ma X. Predictive markers of depression in hypertension. 2018;97(32):e11768
[Crossref]
7- Constantino J, Fonseca V. Pharmacokinetics of antidepressants in patients undergoing hemodialysis: a narrative literature review.
Braz J Psychiatry
. 2019;41(5):441
[Crossref]
8- Gregg L, Carmody T, Le D, Bharadwaj N, Trivedi M, Hedayati S. Depression and the Effect of Sertraline on Inflammatory Biomarkers in Patients with Nondialysis CKD.
Kidney360
. 2020;1(6):436
[Crossref]
9- Li Y, Zhu B, Shen J, Miao L. Depression in maintenance hemodialysis patients: What do we need to know?.
Heliyon
. 2023;9(9):e19383
[Crossref]
10- Gregg L, Carmody T, Le D, Martins G, Trivedi M, Hedayati S. A Systematic Review and Meta-Analysis of Depression and Protein–Energy Wasting in Kidney Disease.
Kidney International Reports
. 2020;5(3):318
[Crossref]
11- O’Shields J, Gibbs J. Depressive symptoms, childhood maltreatment, and allostatic load: The importance of sex differences.
Psychoneuroendocrinology
. 2021;126:105130
[Crossref]
12- Mazumder M, Paul R, Bhattacharya P, Borah A. Neurological sequel of chronic kidney disease: From diminished Acetylcholinesterase activity to mitochondrial dysfunctions, oxidative stress and inflammation in mice brain.
Sci Rep
. 2019;9(1)
[Crossref]